Financial insights of BCAB

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Collaboration and other revenue	-	2,000*	0	-
Research and development expense	4,582	8,738*	9,539	13,684
General and administrative expense	4,726	3,913*	4,250	4,963
Total operating expenses	9,308	12,650*	13,789	18,647
Loss from operations	-9,308	-10,650*	-13,789	-18,647
Interest income	37	294*	133	233
Gain on warrant liability	2,674	3,629*	-2,119	-297
Gain on ppas liability	273	-101*	-	-
Other expense	20	-1,043*	3	-
Total other income	2,964	2,778*	-1,989	-64
Consolidated net loss and comprehensive loss	-6,344	-7,873	-15,778	-18,711

Basic EPS	-4.22	-0.133	-0.27	-0.32
Diluted EPS	-4.22	-0.133	-0.27	-0.32
Basic Average Shares	1,501,649	59,234,063	58,745,343	58,504,396
Diluted Average Shares	1,501,649	59,234,063	58,745,343	58,504,396

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.